Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With Schizophrenia
Clinical trial NCT01095562 · COMPLETED
Trial details
- NCT number
- NCT01095562
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2011-08-01
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.